Your browser doesn't support javascript.
loading
Correction: SETD2 loss sensitizes cells to PI3Kß and AKT inhibition.
Terzo, Esteban A; Lim, Aaron R; Chytil, Anna; Chiang, Yun Chen; Farmer, Leah; Gessner, Kathryn H; Walker, Cheryl Lyn; Jansen, Valerie M; Rathmell, W Kimryn.
Afiliación
  • Terzo EA; Vanderbilt-Ingram Cancer Center, Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville 37232, TN, USA.
  • Lim AR; Current Address: Constellation Pharmaceuticals, Cambridge, MA, USA.
  • Chytil A; Co-first authors.
  • Chiang YC; Vanderbilt-Ingram Cancer Center, Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville 37232, TN, USA.
  • Farmer L; Medical Scientist Training Program, Vanderbilt University School of Medicine, Nashville 37232, TN, USA.
  • Gessner KH; Co-first authors.
  • Walker CL; Vanderbilt-Ingram Cancer Center, Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville 37232, TN, USA.
  • Jansen VM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill 27599, NC, USA.
  • Rathmell WK; Current Address: Novella/IQVIA, Morrisville, NC, USA.
Oncotarget ; 10(59): 6391-6392, 2019 Oct 29.
Article en En | MEDLINE | ID: mdl-31695846
ABSTRACT
[This corrects the article DOI 10.18632/oncotarget.26567.].
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos